Likewise, Wang et al. [27] found that shikonin can induce apoptosis in cisplatin-resistant T24 bladder cancer cells by inhibiting PKM2, which was affected by the RIPK3 inhibitor GSK2399872A (GSK872) or RIP3 si-RNA. Here, PKM is linked to urinary bladder carcinoma.